OU Medicine announces partnership with Mayo Clinic to find COVID-19 treatmentPublished: Monday, April 13, 2020 By: Kayla Branch Source: NewsOK
This content is being provided for free as a public service to our readers during the coronavirus outbreak. Sign up for our daily or breaking newsletters to stay informed. If local news is important to you, consider becoming a digital subscriber to The Oklahoman.
OU Medicine announced Thursday it is partnering with the Mayo Clinic to carry out a new clinical trial to assist with treatment of the sickest COVID-19 patients.
The trial, which OU joined this week, takes plasma from individuals who have recovered from COVID-19 and gives it into those who are still extremely ill with the virus.
“The idea is that if you have recovered from COVID-19, you are very likely ... to have made significant amounts of antibodies,” said Jordan Metcalf, an OU Medicine pulmonary and critical care specialist. “There are some small trials ... that suggest that giving what we call convalescent plasma to patients who are ill improves their clinical status.”
Metcalf said improvements include no longer needing additional oxygen or ventilators and reductions in fevers or other aches.
Read the story on NewsOK.com.